TwoStep Raises $62.5 Million as TS-104 Clears IND

Evidence Company disclosure · Discovery September 10, 2026 · Importance 4/5 · Direction Positive Summary TwoStep Therapeutics closed an oversubscribed $62.5 million Series A and received FDA clearance to begin first-in-human testing of TS-104, a peptide-drug conjugate designed to bind five tumor-associated integrins. The financing…